Casi Pharmaceuticals logo

Casi Pharmaceuticals share price today

(CASI)

Casi Pharmaceuticals share price is $3.08 & ₹264.29 as on 7 Jan 2025, 2.30 'hrs' IST

$3.08

0.2

(6.94%)

Market is closed - opens 8 PM, 07 Jan 2025

View live Casi Pharmaceuticals share price in Dollar and Rupees. Guide to invest in Casi Pharmaceuticals stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Casi Pharmaceuticals, along with analyst recommendations, forecasts, and comprehensive financials.

Casi Pharmaceuticals share price movements

  • Today's Low: $2.87
    Today's High: $3.12

    Day's Volatility :8.17%

  • 52 Weeks Low: $2.05
    52 Weeks High: $8.19

    52 Weeks Volatility :74.97%

Casi Pharmaceuticals Returns

PeriodCasi Pharmaceuticals IncIndex (Russel 2000)
3 Months
-49.47%
0.0%
6 Months
-57.89%
0.0%
1 Year
-53.32%
0.0%
3 Years
-62.11%
-19.8%

Casi Pharmaceuticals Key Statistics

in dollars & INR

Previous Close
$2.88
Open
$2.88
Today's High
$3.12
Today's Low
$2.865
Market Capitalization
$86.6M
Today's Volume
$45.9K
52 Week High
$8.19
52 Week Low
$2.05
Revenue TTM
$23.1M
EBITDA
$-23.1M
Earnings Per Share (EPS)
$-2.03
Profit Margin
-117.68%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-85.43%

How to invest in Casi Pharmaceuticals from India?

It is very easy for Indian residents to invest directly in Casi Pharmaceuticals from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Casi Pharmaceuticals stock in both Indian Rupees (INR) and US Dollars (USD). Search for Casi Pharmaceuticals or CASI on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Casi Pharmaceuticals or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Casi Pharmaceuticals shares which would translate to 0.279 fractional shares of Casi Pharmaceuticals as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Casi Pharmaceuticals, in just a few clicks!

Returns in Casi Pharmaceuticals for Indian investors in Rupees

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Casi Pharmaceuticals investment value today

Current value as on today

₹53,142

Returns

₹46,858

(-46.86%)

Returns from Casi Pharmaceuticals Stock

₹50,081 (-50.08%)

Dollar Returns

₹3,223 (+3.22%)

Indian investors sentiment towards Casi Pharmaceuticals

109%

Period: Oct 8, 2024 to Jan 6, 2025. Change in 30 Days versus previous period

Search volume for Casi Pharmaceuticals on INDmoney from India has grown in the last 30 days as on Jan 7, 2025. 109% more investors are searching Casi Pharmaceuticals in the last 30 days versus the previous period.

Global Institutional Holdings in Casi Pharmaceuticals

  • VR Adviser, LLC

    6.39%

  • Wellington Shields Capital Mgmt LLC

    0.58%

  • ADAR1 Capital Management LLC

    0.42%

  • Wellington Shields & Co., LLC

    0.28%

  • Renaissance Technologies Corp

    0.27%

  • Woodline Partners LP

    0.20%

Analyst Recommendation on Casi Pharmaceuticals

Buy

    85%Buy

    14%Hold

    0%Sell

Based on 7 Wall street analysts offering stock ratings for Casi Pharmaceuticals(by analysts ranked 0 to 5 stars)

Based on 7 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
6
6
6
Hold
1
1
1
Sell
0
0
0

Analyst Forecast on Casi Pharmaceuticals

What analysts predicted

Upside of 94.81%

Current:

$3.08

Target:

$6.00

Insights on Casi Pharmaceuticals

  • Price Movement

    In the last 1 month, CASI stock has moved down by -20.7%
  • Increasing Revenue

    Revenue is up for the last 3 quarters, 3.40M → 7.79M (in $), with an average increase of 31.6% per quarter
  • Decreasing Net Profit

    Netprofit is down for the last 2 quarters, -6.96M → -8.39M (in $), with an average decrease of 20.5% per quarter
  • CASI vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 23.7% return, outperforming this stock by 80.5%
  • CASI vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 55.2% return, outperforming this stock by 117.6%
  • Price to Sales

    ForCASI every $1 of sales, investors are willing to pay $1.7, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $14.2 for every $1 of sales.

Casi Pharmaceuticals Technicals Summary

Sell

Neutral

Buy

Casi Pharmaceuticals is currently in a neutral trading position according to technical analysis indicators.

Casi Pharmaceuticals Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Casi Pharmaceuticals Inc
-25.96%
-57.89%
-53.32%
-62.11%
-90.74%
Regeneron Pharmaceuticals, Inc.
-8.86%
-31.87%
-20.46%
15.59%
87.28%
Biontech Se
-4.16%
43.82%
3.49%
-49.66%
167.6%
Alnylam Pharmaceuticals, Inc.
-8.45%
-8.03%
19.03%
56.02%
98.44%
Vertex Pharmaceuticals Incorporated
-14.11%
-16.23%
-2.87%
81.78%
76.8%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Casi Pharmaceuticals Inc
NA
NA
0.0
0.0
-0.85
-0.27
NA
0.67
Regeneron Pharmaceuticals, Inc.
17.61
17.61
1.06
45.07
0.17
0.07
NA
272.04
Biontech Se
160.8
NA
0.04
-3.11
-0.02
-0.01
NA
79.73
Alnylam Pharmaceuticals, Inc.
NA
NA
-0.49
-0.19
-15.01
-0.03
NA
0.25
Vertex Pharmaceuticals Incorporated
32.84
NA
1.06
0.51
-0.03
0.12
NA
60.65
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Casi Pharmaceuticals Inc
Buy
$86.6M
-90.74%
NA
-117.68%
Regeneron Pharmaceuticals, Inc.
Buy
$78.3B
87.28%
17.61
33.61%
Biontech Se
Buy
$27.3B
167.6%
160.8
-15.36%
Alnylam Pharmaceuticals, Inc.
Buy
$30.4B
98.44%
NA
-15.86%
Vertex Pharmaceuticals Incorporated
Buy
$103.7B
76.8%
32.84
-4.51%

About Casi Pharmaceuticals

CASI Pharmaceuticals, Inc. is a U.S. biopharmaceutical company focused on developing and commercializing innovative therapeutics and pharmaceutical products in China, the United States, and throughout the world. The Company is focused on acquiring, developing and commercializing products that augment its hematology oncology therapeutic focus as well as other areas of unmet medical need. The Company intends to execute its plan to become a leader by launching medicines in the Greater China market leveraging the Company’s China-based regulatory and commercial competencies and its global drug development expertise. The Company’s operations in China are conducted through its wholly-owned subsidiary, CASI Pharmaceuticals (China) Co., Ltd. (“CASI China”), which is located in Beijing, China. The Company has built a commercial team of over 70 hematology and oncology sales and marketing specialists based in China.
Organization
Casi Pharmaceuticals
Employees
176
CEO
Dr. Wei-Wu He Ph.D.
Industry
Health Technology

Management People of Casi Pharmaceuticals

NameTitle
Dr. Wei-Wu He Ph.D.
Chairman & CEO
Dr. Alexander A. Zukiwski M.D.
Executive VP & Chief Medical Officer
Dr. Wei Zhang Ph.D.
Senior Vice President
Dr. Daniel Lang M.D.
MD, Senior VP & Chief Financial Officer
Ms. Chunhua Wang
Chief Operating Officer
Ms. Wei Gao
General Counsel
Dr. James E. Goldschmidt Ph.D.
Chief Business Development Officer
Mr. Hai Huang
Global Chief Commercial Officer & GM of CASI China
Ms. Amanda Cui
VP & Global Controller
Ms. Kun Qian
VP & Global Controller

Important FAQs about investing in Casi Pharmaceuticals from India :

What is Casi Pharmaceuticals share price today?

Casi Pharmaceuticals share price today stands at $3.08, Open: $2.88 ; Previous Close: $2.88 ; High: $3.12 ; Low: $2.87 ; 52 Week High: $8.19 ; 52 Week Low: $2.05. The stock opens at $2.88, after a previous close of $2.88. The stock reached a daily high of $3.12 and a low of $2.87, with a 52-week high of $8.19 and a 52-week low of $2.05.

Can Indians buy Casi Pharmaceuticals shares?

Yes, Indians can invest in the Casi Pharmaceuticals (CASI) from India.

With INDmoney, you can buy Casi Pharmaceuticals at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Casi Pharmaceuticals at zero transaction cost.

How can I buy Casi Pharmaceuticals shares from India?

It is very easy to buy Casi Pharmaceuticals from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Casi Pharmaceuticals be purchased?

Yes, you can buy fractional shares of Casi Pharmaceuticals with INDmoney app.

What are the documents required to start investing in Casi Pharmaceuticals stocks?

To start investing in Casi Pharmaceuticals, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Casi Pharmaceuticals

Today’s highest price of Casi Pharmaceuticals (CASI) is $3.12.

Today’s lowest price of Casi Pharmaceuticals (CASI) is $2.87.

What is today's market capitalisation of Casi Pharmaceuticals

Today's market capitalisation of Casi Pharmaceuticals CASI is 86.6M

What is the 52 Week High and Low Range of Casi Pharmaceuticals

  • 52 Week High

    $8.19

  • 52 Week Low

    $2.05

What are the historical returns of Casi Pharmaceuticals?

  • 1 Month Returns

    -25.96%

  • 3 Months Returns

    -57.89%

  • 1 Year Returns

    -53.32%

  • 5 Years Returns

    -90.74%

Who is the Chief Executive Officer (CEO) of Casi Pharmaceuticals

Dr. Wei-Wu He Ph.D. is the current Chief Executive Officer (CEO) of Casi Pharmaceuticals.